Pharmacokinetic Pharmacodynamic

Related by string. pharmacokinetic pharmacodynamic * Pharmacokinetics . pharmacokinetics . pharmacokinetic : pharmacokinetics PK . pharmacokinetic PK . safety tolerability pharmacokinetics / Pharmacodynamics . pharmacodynamics . pharmacodynamic : pharmacodynamic parameters . safety tolerability pharmacodynamics . pharmacodynamic profile * pharmacokinetic pharmacodynamic PK PD *

Related by context. Frequent words. (Click for all words.) 66 Clinical Trial Results 65 Pivotal Phase 65 Drug Candidate 64 Heart Failure Patients 64 Meta Analysis 64 Tolerability 63 Metastatic Melanoma 63 Preclinical Data 63 Pivotal Phase III 63 Phase III Clinical Trial 62 Postmenopausal Women 62 Immunogenicity 62 Pharmacokinetic 62 Phase III Trial 61 Metastatic Colorectal Cancer 61 Completes Enrollment 61 Pivotal Trial 60 Inhibits 60 Bortezomib 60 Elderly Patients 60 Presents Positive 59 Overactive Bladder 59 Monotherapy 59 Pulmonary Arterial Hypertension 59 Initiates Phase 59 Chronic Hepatitis C 59 Small Molecule 59 Epratuzumab 59 Fidaxomicin 59 Multicenter 59 Study Demonstrates 59 SABCS 58 Combination Therapy 58 Cethromycin 58 Targeted Therapy 58 Patients Treated 57 Pharmacokinetics 57 C Reactive Protein 57 Systematic Review 57 J Am Coll 57 KRN# 57 pharmacodynamic effects 57 Acute Myocardial Infarction 57 Oritavancin 57 Atopic Dermatitis 57 J Am Acad 56 Solid Tumors 56 Benign Prostatic Hyperplasia 56 Induces 56 Clinical Outcomes 56 Low Dose 56 Clinical Study 56 Bevacizumab 55 Non Invasive 55 #:#-# [023] 55 Chronic Lymphocytic Leukemia 55 Randomized Controlled Trial 55 Int J 55 Cardiovascular Risk 55 Traficet EN 55 Ischemic 54 Am J Clin 54 Advanced Prostate Cancer 54 Cost Effectiveness 54 Phase 1b 54 Hepatic 54 administered subcutaneously 54 Apixaban 54 Anticoagulation 54 Celecoxib 54 Pioglitazone 54 Lenalidomide 53 HALTS 53 Clinical Trial 53 Prophylactic 53 Significantly Reduces 53 Pathogenesis 53 Phase Ib clinical 53 Free Full Text 53 phase IIb clinical 53 Extended Release 53 Pharmacological 53 Phase 1b trial 52 Infliximab 52 prospective observational 52 Carfilzomib 52 Myocardial 52 decitabine 52 FDA Approves 52 nab paclitaxel 52 Prophylaxis 52 Laquinimod 52 Efficacy 52 Pegasys ® 52 Arch Neurol 52 Natalizumab 52 #:#-# [029] 52 #:#-# [031] 52 Stenting 52 CrossRef Medline 52 Pirfenidone

Back to home page